CD274 and neoplasm: Kulasinghe et al. reported a method to identify potential candidates for PD-L1 therapy.67 This involved a microfluidic chip with a spiral channel utilizing Dean flows72 (Fig. 4D) to isolate circulating tumour cells (CTC) from blood of patients with squamous cell carcinoma.